The price of The Chemours Company (NYSE:CC) shares last traded on Wall Street rose 1.50% to $35.89.
Based on available information, 13 analysts follow The Chemours Company (NYSE:CC). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $64.00 and a low of $25.00, we find $37.00. Given the previous closing price of $35.36, this indicates a potential upside of 4.64 percent. CC stock price is now 17.79% away from the 50-day moving average and 16.00% away from the 200-day moving average. The market capitalization of the company currently stands at $5.44B.
Among analysts, 8 rate the stock a hold while 3 rate it a buy. Brokers who have rated the stock have averaged $37.55 as their price target over the next twelve months.
With the price target reduced from $41 to $37, BofA Securities Downgraded its rating from Buy to Neutral for The Chemours Company (NYSE: CC).
In other news, Newman Mark, President and CEO bought 7,661 shares of the company’s stock on Jun 09. The stock was bought for $265,300 at an average price of $34.63. Upon completion of the transaction, the President and CEO now directly owns 266,955 shares in the company, valued at $9.58 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 09, SVP Corp Communications & CBO Scarborough Alvenia sold 5,125 shares of the business’s stock. A total of $165,537 was realized by selling the stock at an average price of $32.30. This leaves the insider owning 13,890 shares of the company worth $0.5 million. Insiders disposed of 245,136 shares of company stock worth roughly $8.8 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CC stock. A new stake in The Chemours Company shares was purchased by EPOCH INVESTMENT PARTNERS, INC. during the first quarter worth $11,878,000. HRT FINANCIAL LP invested $10,805,000 in shares of CC during the first quarter. In the first quarter, TWINBEECH CAPITAL LP acquired a new stake in The Chemours Company valued at approximately $6,037,000. HUSSMAN STRATEGIC ADVISORS, INC. acquired a new stake in CC for approximately $3,338,000. COVALIS CAPITAL LLP purchased a new stake in CC valued at around $3,224,000 in the second quarter. In total, there are 607 active investors with 76.70% ownership of the company’s stock.
A candlestick chart of The Chemours Company (NYSE: CC) showed a price of $35.35 on Thursday morning. During the past 12 months, The Chemours Company has had a low of $23.58 and a high of $38.36. As of last week, the company has a debt-to-equity ratio of 2.95, a current ratio of 1.80, and a quick ratio of 1.00. According to the stock market information, the enterprise value for the company is $8.26B, which is based on a 11.61 price-to-earnings ratio, a 1.10 price-to-earnings-growth ratio, and a beta of 1.92. The fifty day moving average price for CC is $30.47 and a two-hundred day moving average price translates $30.94 for the stock.
The latest earnings results from The Chemours Company (NYSE: CC) was released for Mar, 2023. According to the Specialty Chemicals Company, earnings per share came in at $0.98, beating analysts’ expectations of $0.47 by 0.51. This compares to $1.43 EPS in the same period last year. The net profit margin was 7.40% and return on equity was 40.50% for CC. The company reported revenue of $1.54 billion for the quarter, compared to $1.76 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -12.93 percent. For the current quarter, analysts expect CC to generate $1.69B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 06/15/2023. Investors who held shares on 05/15/2023 were paid a $0.25 dividend. On an annualized basis, this represents a $1.00 dividend and a 2.79% percent yield. There was an ex-dividend date of 05/12/2023 for this dividend. In terms of dividend payout ratio, CC is presently at 31.70%.
The Chemours Company(CC) Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
